Stocktoria

Anebulo Pharmaceuticals, Inc. ANEB

OTC · stock · Pharmaceutical Preparations · website · IPO 2021-05-07 · LEI

Anebulo Pharmaceuticals, Inc. statistics & valuation

Market cap$16.1M
P / B1.4×
Return on equity-72.8%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20212022202320242025
Operating margin (%)
20212022202320242025
Return on equity (%)
-141.30% -45.30% -110.70% -215.10% -72.80% 20212022202320242025
Shares outstanding
23.3M 23.3M 25.6M 25.9M 41.1M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-139.70% -43.80% -100.50% -201.40% -69.90% 20212022202320242025
Free cash flow margin (%)
20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
$0.29 -$0.47 -$0.32 -$0.25 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Return on assets-69.9%-201.4%-100.5%-43.8%-139.7%
Return on equity-72.8%-215.1%-110.7%-45.3%-141.3%

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.